02:01 PM EDT, 10/30/2025 (MT Newswires) -- AstraZeneca ( AZN ) reported positive results from its Phase 3 trial of gefurulimab, showing statistically significant and clinically meaningful improvements in patients' ability to perform daily activities with generalized Myasthenia Gravis, a chronic autoimmune neuromuscular disorder. The trial met its primary endpoint, demonstrating a significant improvement in the Myasthenia Gravis Activities of...

02:05 PM EDT, 10/30/2025 (MT Newswires) -- Roblox ( RBLX ) raised its full-year bookings guidance, while the video game platform flagged potential margin pressures from increased investments in infrastructure and people. For fiscal 2025, the company now expects bookings of $6.57 billion to $6.62 billion, representing growth of 50% to 51% year over year, up from its prior outlook...

02:10 PM EDT, 10/30/2025 (MT Newswires) -- Abeona Therapeutics ( ABEO ) said Thursday its autologous gene therapy Zevaskyn received a permanent Healthcare Common Procedure Coding System J-code from the Centers for Medicare and Medicaid Services. The new product-specific identifier, J3389 - Topical administration, prademagene zamikeracel, per treatment - will take effect on Jan. 1, 2026, the company added. Zevaskyn...

02:10 PM EDT, 10/30/2025 (MT Newswires) -- Price: 89.32, Change: +0.23, Percent Change: +0.26 ...